Business
SANUWAVE Health Secures Customer Medical Device Financing
A CIT Facility Helps Expand the Market for SANUWAVE’s Products SUWANEE, GA, March 24, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- SANUWAVE Health, Inc.
About this update from Sanuwave Health, Inc.
[{"type":"text","content":" A CIT Facility Helps Expand the Market for SANUWAVE’s Products SUWANEE, GA, March 24, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- SANUWAVE Health, Inc. (OTCQB: SNWV), focused on the development and commercialization of a robust and innovative advanced wound care product portfolio for the repair and regeneration of skin and vascular structures, announced today that it has secured customer medical device financing from CIT Business Capital. “The new partnership with CIT is a great step in bringing our ENERGY FIRST platform to our customers and ultimately the patients that will benefit from our novel treatment of wounds. CIT gives our customers customizable affordable options to finance our technology to fit the needs of individual practices and institutions. For SANUWAVE the partnership enables us to grow the market and recognize revenue very quickly, allowing SANUWAVE to reinvest in our team and technologies. We rolled out the new purchase options to our customers the second week of March and are excited to establish a long-lasting, mutually beneficial relationship with CIT,” stated Jack Schlechtweg, Chief Revenue Officer of SANUWAVE Health. “CIT is excited to be partnering with SANUWAVE to offer low monthly payment options to SANUWAVE customers, making SANUWAVE’s products accessible to practices and organizations of all sizes and allowing the products to pay for themselves. CIT is a leading national bank, and CIT’s Business Capital division focuses on empowering small-, mid-, and large-cap businesses by providing equipment financing solutions via technology-enabled platforms and market-leading structuring expertise gained from over a century of experience since our founding in 1908,” commented Rich Cady, Lending Solutions Manager for CIT. About SANUWAVE Health, Inc. SANUWAVE Health, Inc. (OTCQB: SNWV) is focused on the research, development, and commercialization of its patented noninvasive and biological response activating medical systems for the repair and regeneration of skin, musculoskeletal tissue, and vascular structures. Through its recent acquisition of the UltraMIST® assets, SANUWAVE now combines two highly complementary and market-cleared energy transfer technologies used in the dermaPACE® and UltraMIST® Systems and two human tissue biologic products (Biovance® and Interfyl®), which creates a platform of scale with ...